US: Noted antitrust attorney to lead nationwide class action suit over EpiPen pricing
A federal judge in Kansas has appointed Dallas lawyer Warren T. Burns and two other attorneys to lead a nationwide class action against Mylan NV and other defendants over pricing practices involving the EpiPen allergy treatment. Burns is a partner at Burns Charest, a litigation boutique with offices in Dallas and New Orleans.
Mylan, the US distributor of EpiPens, sparked outrage after raising the price of its life-saving product from $100 in 2008 to more than $600 by 2016. Congress and federal agencies have since opened investigations into EpiPen pricing.
“This suit is about taking a stand for Americans who suffer life-threatening conditions,” Burns said. “We intend to send a message to Mylan and other companies that preying on the weak and the sick is no longer an accepted method of padding their bottom line.”
Full Content: Yahoo
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
BHP Unveils £31bn Mining Megamerger Proposal with Anglo American
Apr 25, 2024 by
nhoch@pymnts.com
ByteDance Prefers Shutdown Over Sale of TikTok Amid US Ban Threats
Apr 25, 2024 by
CPI
FCC Votes to Restore Net Neutrality Rules
Apr 25, 2024 by
nhoch@pymnts.com
Apple Rejects Spotify’s Updated App Over In-App Pricing Disclosure
Apr 25, 2024 by
CPI
FCC Set to Reinstate Net Neutrality Rules Today
Apr 25, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI